# Randomized Trial of EUS Neurolysis in Pancreas Cancer

> **NCT00279292** · PHASE3 · COMPLETED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 26 (estimated)

## Conditions studied

- Pancreatic Neoplasms

## Interventions

- **PROCEDURE:** Celiac Plexus Neurolysis

## Key facts

- **NCT ID:** NCT00279292
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** 2007-01
- **Final completion:** 2007-01
- **Target enrollment:** 26 (ESTIMATED)
- **Last updated:** 2015-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00279292

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00279292, "Randomized Trial of EUS Neurolysis in Pancreas Cancer". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT00279292. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*